Sourcing Strategies for API Supply Chain Resilience
The pharmaceutical supply chain, which moves drugs from raw materials to patients, begins with Active Pharmaceutical Ingredients (APIs). With the majority of APIs manufactured primarily in China and India, domestic drug supplies remain vulnerable to single points of failure. Risks associated with sourcing APIs include geographic concentration and lack of transparency in upstream supply chains.…









